Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02286466 · ClinicalTrials.gov registry record · NA
Mobile App of CBT for Anxiety and Cancer
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 145
- Enrollment target
NCT02286466: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02286466 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 145 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02286466, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 145 participants
- Enrollment target
Study Summary
The proposed study seeks to implement a randomized controlled trial to evaluate the effectiveness and generalizability of an efficacious cognitive-behavioral therapy (CBT) intervention for use as a self-administered mobile application (mobile app) to treat anxiety in patients with metastatic cancer.
Interventions
- BEHAVIORAL Health Education Program
- BEHAVIORAL CBT Mobile Application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2015-02-18 |
| Est. Completion | 2016-10-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02286466
The ClinicalTrials.gov registry entry for NCT02286466 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Health Education Program is the first listed.
NCT02286466 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02286466 about?
NCT02286466 is a clinical study titled "Mobile App of CBT for Anxiety and Cancer". The proposed study seeks to implement a randomized controlled trial to evaluate the effectiveness and generalizability of an efficacious cognitive-behavioral therapy (CBT) intervention for use as a self-administered mobile application (mobile app) to treat anxiety in patients with metastatic cancer.
What is the current status of trial NCT02286466?
This trial is currently completed. It is a NA study. The enrollment target is 145 participants. The study started on 2015-02-18. Estimated completion is 2016-10-25.
What interventions are being tested in trial NCT02286466?
The interventions under investigation include: Health Education Program (BEHAVIORAL), CBT Mobile Application (BEHAVIORAL).
Who is sponsoring clinical trial NCT02286466?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.